JP2024016237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024016237A5 JP2024016237A5 JP2023192683A JP2023192683A JP2024016237A5 JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5 JP 2023192683 A JP2023192683 A JP 2023192683A JP 2023192683 A JP2023192683 A JP 2023192683A JP 2024016237 A5 JP2024016237 A5 JP 2024016237A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- dose
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003112 inhibitor Substances 0.000 claims 22
- 102000003816 Interleukin-13 Human genes 0.000 claims 14
- 108090000176 Interleukin-13 Proteins 0.000 claims 14
- 102000004388 Interleukin-4 Human genes 0.000 claims 13
- 108090000978 Interleukin-4 Proteins 0.000 claims 13
- 230000037361 pathway Effects 0.000 claims 13
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 206010064212 Eosinophilic oesophagitis Diseases 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 201000000708 eosinophilic esophagitis Diseases 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 208000019505 Deglutition disease Diseases 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 208000004262 Food Hypersensitivity Diseases 0.000 claims 2
- 239000003246 corticosteroid Substances 0.000 claims 2
- 230000010339 dilation Effects 0.000 claims 2
- 235000020932 food allergy Nutrition 0.000 claims 2
- 229940126409 proton pump inhibitor Drugs 0.000 claims 2
- 239000000612 proton pump inhibitor Substances 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 102000006440 Chemokine CCL26 Human genes 0.000 claims 1
- 108010083698 Chemokine CCL26 Proteins 0.000 claims 1
- 206010009137 Chronic sinusitis Diseases 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 102000003777 Interleukin-1 beta Human genes 0.000 claims 1
- 108090000193 Interleukin-1 beta Proteins 0.000 claims 1
- 102000002171 Interleukin-4/interleukin-13 Human genes 0.000 claims 1
- 108050009538 Interleukin-4/interleukin-13 Proteins 0.000 claims 1
- 102000000743 Interleukin-5 Human genes 0.000 claims 1
- 108010002616 Interleukin-5 Proteins 0.000 claims 1
- 102000000585 Interleukin-9 Human genes 0.000 claims 1
- 108010002335 Interleukin-9 Proteins 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 208000024780 Urticaria Diseases 0.000 claims 1
- 239000013566 allergen Substances 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000000378 dietary effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229950003468 dupilumab Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000003862 glucocorticoid Substances 0.000 claims 1
- 229960003444 immunosuppressant agent Drugs 0.000 claims 1
- 230000001861 immunosuppressant effect Effects 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 229940124624 oral corticosteroid Drugs 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 claims 1
- BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 229940125379 topical corticosteroid Drugs 0.000 claims 1
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 claims 1
- 239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762541242P | 2017-08-04 | 2017-08-04 | |
| US62/541,242 | 2017-08-04 | ||
| US201762561593P | 2017-09-21 | 2017-09-21 | |
| US62/561,593 | 2017-09-21 | ||
| EP18305252.1 | 2018-03-08 | ||
| EP18305252 | 2018-03-08 | ||
| JP2020505844A JP7417515B2 (ja) | 2017-08-04 | 2018-08-03 | 活動性好酸球性食道炎を治療する方法 |
| PCT/US2018/045195 WO2019028367A1 (en) | 2017-08-04 | 2018-08-03 | METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505844A Division JP7417515B2 (ja) | 2017-08-04 | 2018-08-03 | 活動性好酸球性食道炎を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024016237A JP2024016237A (ja) | 2024-02-06 |
| JP2024016237A5 true JP2024016237A5 (enrdf_load_stackoverflow) | 2024-10-17 |
Family
ID=63113646
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505844A Active JP7417515B2 (ja) | 2017-08-04 | 2018-08-03 | 活動性好酸球性食道炎を治療する方法 |
| JP2023192683A Pending JP2024016237A (ja) | 2017-08-04 | 2023-11-13 | 活動性好酸球性食道炎を治療する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505844A Active JP7417515B2 (ja) | 2017-08-04 | 2018-08-03 | 活動性好酸球性食道炎を治療する方法 |
Country Status (9)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3174431A1 (en) * | 2020-05-22 | 2021-11-25 | Jennifer D. Hamilton | Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor |
| AU2023259287A1 (en) * | 2022-04-29 | 2024-12-12 | Akeso Biopharma, Inc | Anti-human il-4ra antibody and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI682781B (zh) * | 2013-07-11 | 2020-01-21 | 美商再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| KR20160068802A (ko) * | 2013-10-23 | 2016-06-15 | 제넨테크, 인크. | 호산구성 장애를 진단 및 치료하는 방법 |
| KR20170123315A (ko) * | 2015-03-11 | 2017-11-07 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Tslp 결합 단백질 |
-
2018
- 2018-08-02 IL IL315556A patent/IL315556A/en unknown
- 2018-08-03 MX MX2020001305A patent/MX2020001305A/es unknown
- 2018-08-03 CA CA3071528A patent/CA3071528A1/en active Pending
- 2018-08-03 AU AU2018311981A patent/AU2018311981B2/en active Active
- 2018-08-03 MA MA049744A patent/MA49744A/fr unknown
- 2018-08-03 CN CN201880050334.6A patent/CN111032084A/zh active Pending
- 2018-08-03 JP JP2020505844A patent/JP7417515B2/ja active Active
- 2018-08-03 IL IL272245A patent/IL272245B2/en unknown
- 2018-08-03 EP EP18750578.9A patent/EP3661551A1/en active Pending
- 2018-08-03 KR KR1020207006346A patent/KR102719720B1/ko active Active
- 2018-08-03 KR KR1020247034392A patent/KR20240152980A/ko active Pending
-
2020
- 2020-01-31 MX MX2024012777A patent/MX2024012777A/es unknown
-
2023
- 2023-11-13 JP JP2023192683A patent/JP2024016237A/ja active Pending
-
2025
- 2025-02-12 AU AU2025200955A patent/AU2025200955A1/en active Pending